Levine S D, Kachadorian W A, Levin D N, Schlondorff D
J Clin Invest. 1981 Mar;67(3):662-72. doi: 10.1172/JCI110081.
Calcium ion plays a major regulatory role in many hormone-stimulated systems. To determine the site of calcium's action in the toad urinary bladder, we examined the effect of trifluoperazine, a compound that binds specifically to the calcium binding protein, calmodulin, and thereby prevents activation of enzymes by the calcium- calmodulin complex. 10 microM trifluoperazine inhibited vasopressin stimulation of water flow, but did not alter vasopressin's effects on urea permeability or short-circuit current. Trifluoperazine also blocked stimulation of water flow by cyclic AMP and methylisobutylxanthine, implying a "postcyclic AMP" site of action. Consistent with these results, trifluoperazine did not decrease epithelial cyclic AMP content or the cyclic AMP-dependent protein kinase activity ratio. Assay of bladder epithelial supernate demonstrated calmodulin-like activity of 1.5 U/microgram protein. Morphologic studies of vasopressin-treated bladders revealed that trifluoperazine did not alter the volume density of cytoplasmic microtubules or significantly decrease the number of fusions between cytoplasmic, aggregate-containing, elongated vesicles and the luminal membrane. Nonetheless, the frequency of luminal membrane aggregates, structures that correlate well with luminal membrane water permeability, was decreased by greater than 50%. Thus, trifluoperazine appears to inhibit the movement of intramembranous particle aggregates from the fused intracellular membranes to the luminal membrane, perhaps by blocking an effect of calcium on microfilament function.
钙离子在许多激素刺激系统中发挥着主要的调节作用。为了确定钙在蟾蜍膀胱中的作用位点,我们研究了三氟拉嗪的作用,该化合物能特异性结合钙结合蛋白钙调蛋白,从而阻止钙 - 钙调蛋白复合物对酶的激活。10微摩尔的三氟拉嗪抑制了血管加压素对水流动的刺激,但并未改变血管加压素对尿素通透性或短路电流的影响。三氟拉嗪还阻断了环磷酸腺苷(cAMP)和甲基异丁基黄嘌呤对水流动的刺激,这意味着其作用位点在“cAMP之后”。与这些结果一致,三氟拉嗪并未降低上皮细胞内cAMP含量或cAMP依赖性蛋白激酶活性比值。对膀胱上皮细胞上清液的检测显示,其钙调蛋白样活性为1.5单位/微克蛋白质。对血管加压素处理过的膀胱进行形态学研究发现,三氟拉嗪并未改变细胞质微管的体积密度,也未显著减少含聚集体的细长细胞质囊泡与腔膜之间的融合数量。尽管如此,与腔膜水通透性密切相关的腔膜聚集体的频率降低了50%以上。因此,三氟拉嗪似乎抑制了膜内颗粒聚集体从融合的细胞内膜向腔膜的移动,这可能是通过阻断钙对微丝功能的影响来实现的。